These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 7654476)

  • 21. Toxicologic and pharmacologic considerations in the choice of empiric parenteral antibiotics.
    Glauser MP; Neftel KA
    Am J Med; 1986 May; 80(5C):64-9. PubMed ID: 3717190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aminoglycoside antibiotics from a clinical viewpoint].
    Lüthy R
    Schweiz Med Wochenschr; 1976 Mar; 106(13):450-5. PubMed ID: 1265459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminoglycoside-induced nephrotoxicity.
    Wargo KA; Edwards JD
    J Pharm Pract; 2014 Dec; 27(6):573-7. PubMed ID: 25199523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephrotoxicity of aminoglycosides and cephalosporins in combination.
    Rankin GO; Sutherland CH
    Adverse Drug React Acute Poisoning Rev; 1989; 8(2):73-88. PubMed ID: 2672726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminoglycoside therapy in infectious diseases.
    Poulikakos P; Falagas ME
    Expert Opin Pharmacother; 2013 Aug; 14(12):1585-97. PubMed ID: 23746121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminoglycoside-induced vestibular injury: maintaining a sense of balance.
    Ariano RE; Zelenitsky SA; Kassum DA
    Ann Pharmacother; 2008 Sep; 42(9):1282-9. PubMed ID: 18648019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing use of aminoglycosides in the critically ill.
    Rea RS; Capitano B
    Semin Respir Crit Care Med; 2007 Dec; 28(6):596-603. PubMed ID: 18095223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Considerations regarding clinical safety and tolerability of antibiotics in serious and nosocomial infections.
    Smith CR
    Clin Ther; 1981; 4 Suppl A():133-45. PubMed ID: 7034939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of aminoglycosides in modern therapy.
    Beaucaire G
    J Chemother; 1995 Jun; 7 Suppl 2():111-23. PubMed ID: 8622100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aminoglycosides and polymyxins].
    Molina J; Cordero E; Palomino J; Pachón J
    Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):178-88. PubMed ID: 19303668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do we still need the aminoglycosides?
    Durante-Mangoni E; Grammatikos A; Utili R; Falagas ME
    Int J Antimicrob Agents; 2009 Mar; 33(3):201-5. PubMed ID: 18976888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Aminoglycosides in pediatrics].
    Schaad UB
    Schweiz Med Wochenschr Suppl; 1996; 76():34S-38S. PubMed ID: 8677417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminoglycoside nephrotoxicity: pathogenesis and prevention.
    Cronin RE
    Clin Nephrol; 1979 May; 11(5):251-6. PubMed ID: 378495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of netilmicin and other aminoglycosides on renal function. A survey of the literature on the nephrotoxicity of netilmicin.
    Dahlager JI
    Scand J Infect Dis Suppl; 1980; Suppl 23():96-102. PubMed ID: 7010549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glomerular nephrotoxicity of aminoglycosides.
    Martínez-Salgado C; López-Hernández FJ; López-Novoa JM
    Toxicol Appl Pharmacol; 2007 Aug; 223(1):86-98. PubMed ID: 17602717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parenteral aminoglycoside therapy. Selection, administration and monitoring.
    Kumana CR; Yuen KY
    Drugs; 1994 Jun; 47(6):902-13. PubMed ID: 7521830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronopharmacokinetics of once daily dosed aminoglycosides in hospitalized infectious patients.
    van Maarseveen E; Man WH; Proost J; Neef C; Touw D
    Int J Clin Pharm; 2015 Apr; 37(2):342-7. PubMed ID: 25616626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Level of evidence for therapeutic drug monitoring of aminoglycosides].
    Venisse N; Boulamery A;
    Therapie; 2011; 66(1):39-44. PubMed ID: 21466776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New trends in aminoglycoside dosing.
    Kuharcik CM; Craig AC
    ANNA J; 1994 Dec; 21(7):447-8, 468. PubMed ID: 7872827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.